These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17884629)

  • 21. Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher's disease.
    Bleijlevens B; van Breemen MJ; Donker-Koopman WE; de Koster CG; Aerts JM
    Anal Biochem; 2008 Jan; 372(1):52-61. PubMed ID: 17976508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
    Kawahara S; Kato A; Oshimi K; Ida H
    Rinsho Ketsueki; 2008 May; 49(5):335-9. PubMed ID: 18572811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambroxol as Therapy for Gaucher Disease-Ambitious but Ambivalent.
    Weinreb NJ; Goker-Alpan O
    JAMA Netw Open; 2023 Jun; 6(6):e2319336. PubMed ID: 37342045
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzyme, substrate, and myeloma in Gaucher disease.
    Hughes DA
    Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
    de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
    Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Cohen IJ
    Clin Genet; 2007 Aug; 72(2):160; author reply 161. PubMed ID: 17661822
    [No Abstract]   [Full Text] [Related]  

  • 27. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B; Salor O; Yalçin B; Gürakan F; Güçer S; Büyükpamukçu M
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveitis in Gaucher disease.
    Roos JC
    Am J Ophthalmol; 2006 Feb; 141(2):421; author reply 421-2. PubMed ID: 16458721
    [No Abstract]   [Full Text] [Related]  

  • 29. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hruska KS; LaMarca ME; Scott CR; Sidransky E
    Hum Mutat; 2008 May; 29(5):567-83. PubMed ID: 18338393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H;H255Q] double mutant allele.
    Santamaria R; Michelakakis H; Moraitou M; Dimitriou E; Dominissini S; Grossi S; Sánchez-Ollé G; Chabás A; Pittis MG; Filocamo M; Vilageliu L; Grinberg D
    Hum Mutat; 2008 Jun; 29(6):E58-67. PubMed ID: 18429048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerezyme: a case study.
    Edmunds T
    Dev Biol Stand; 1998; 96():131-40. PubMed ID: 9890527
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
    Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biochemical and molecular diagnosis of Gaucher disease in Tunisia].
    Dandana A; Ferchichi S; Khedhiri S; Chkioua L; Jaidane Z; Monastiri K; Ben Khelifa S; Ben Mansour R; Maire I; Froissart R; Bonnet V; Laradi S; Miled A
    Ann Biol Clin (Paris); 2007; 65(6):647-52. PubMed ID: 18039610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
    Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD
    Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions.
    Borry P; Clarke A; Dierickx K
    Eur J Hum Genet; 2008 Feb; 16(2):139-40. PubMed ID: 18043719
    [No Abstract]   [Full Text] [Related]  

  • 36. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy.
    Langeveld M; de Fost M; Aerts JM; Sauerwein HP; Hollak CE
    Blood Cells Mol Dis; 2008; 40(3):428-32. PubMed ID: 17950007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient.
    Cajaiba MM; Reyes-Múgica M
    Hum Pathol; 2009 Apr; 40(4):594-8. PubMed ID: 19084264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratification.
    Welsh NJ; Gewinner CA; Mistry K; Koglin M; Cooke J; Butler M; Powney B; Roberts M; Staddon JM; Schapira AHV
    Haematologica; 2020 May; 105(5):e206-e209. PubMed ID: 31558665
    [No Abstract]   [Full Text] [Related]  

  • 39. Shire dumps Dynepo.
    Ratner M
    Nat Biotechnol; 2008 Dec; 26(12):1322-3. PubMed ID: 19060856
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of small molecules that modify the protein folding activity of heat shock protein 70.
    Wisén S; Gestwicki JE
    Anal Biochem; 2008 Mar; 374(2):371-7. PubMed ID: 18191466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.